FDA
-
-
-
-
-
-
-
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results
-
-
-
-
-
-
-
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
CTI BioPharma (CTIC) Presents Pivotal Data from Pacritinib Program
-
-
-
-
-
-
-
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
CTI BioPharma to Present at the Cowen 42nd Annual Healthcare Conference
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

